Despite having greater morbidity and mortality than other Australians, Aboriginal and Torres Strait Islander people underuse the Pharmaceutical Benefits Scheme. Increasing their access to medicines could improve their health. To improve access, there are some specific medicines on the Pharmaceutical Benefits Scheme for Aboriginal and Torres Strait Islander people. There is also the Indigenous Chronic Disease Package which will assist with the cost of medicines. Incentives are being provided for doctors to enrol their Aboriginal and Torres Strait Islander patients to obtain these benefits. A 25-year-old man with schizophrenia presented as an emergency with severe pain and swelling of his left jaw and neck. He was febrile (38.9 o C) and could only open his jaw 5 mm.
Introduction
Aboriginal and Torres Strait Islander people suffer from the burden of chronic disease at a rate 2.5 times that of other Australians, with approximately one-third of the burden due to vascular diseases. 1 Cardiovascular disease, chronic kidney disease and diabetes are the main problems and share the common risk factors of smoking, high blood pressure, high cholesterol, physical inactivity, obesity and a low intake of fresh fruit and vegetables. 1 This increase in the burden of chronic disease should be reflected in an increase in the prescription of drugs for the treatment of heart disease, diabetes, chronic kidney disease, mental health and lung conditions. However, data from the Pharmaceutical Benefits Scheme (PBS) show that Aboriginal and Torres Strait Islander people access the PBS at a lower rate than other Australians. 2 Indigenous people also underuse primary healthcare consultations and specialist care. 2 Table 1 shows the current drugs available as authority prescriptions on the PBS specifically for Aboriginal and Torres Strait Islander people. 3 The rationale for subsidising these drugs is the higher rate of disease seen in the Aboriginal and Torres Strait Islander population compared to the non-indigenous population.
PBS drugs specifically for Aboriginal and Torres Strait Islander people
Indigenous people suffer higher rates of chronic suppurative otitis media (particularly children 4, 5 ), have higher rates of fungal infections, 6 are more likely to drink alcohol at harmful levels (thiamine prophylaxis), 7 have smoking rates 2-3 times higher than other Australians (nicotine replacement therapy) 8 and have higher rates of whipworm, strongyloidiasis and hookworm (albendazole). 9 
General practitioners working in Aboriginal and Torres Strait
Islander Community Controlled Health Services are very much aware of this initiative and regularly prescribe these drugs for the benefit of their patients. However, many Aboriginal and Torres Strait Islander people access mainstream general practice where some doctors may be unaware of this important initiative for improving their access to these drugs.
Affordability of drugs
The price of medicines is a major barrier for Aboriginal and 
What does this mean for your practice?
Aboriginal and Torres Strait Islander Community Controlled Health Services will have no barriers to identifying eligible 
